Nifty
Sensex
:
:
17629.50
59141.16
110.05 (0.63%)
417.96 (0.71%)

Pharmaceuticals & Drugs - Domestic

Rating :
56/99

BSE: 500660 | NSE: GLAXO

1572.95
16-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  1560.00
  •  1604.90
  •  1560.00
  •  1559.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  201776
  •  3202.74
  •  1801.00
  •  1376.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 26,345.18
  • 71.51
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 25,187.22
  • 1.93%
  • 16.26

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 0.40%
  • 10.86%
  • FII
  • DII
  • Others
  • 1.61%
  • 9.40%
  • 2.73%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 1.92
  • 0.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 10.66
  • 2.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 1.24
  • -7.01

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 60.41
  • 62.08
  • 64.62

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.19
  • 12.87
  • 13.57

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.04
  • 35.69
  • 33.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
789.99
648.59
21.80%
813.75
775.80
4.89%
857.20
778.59
10.10%
879.32
882.02
-0.31%
Expenses
638.32
534.52
19.42%
642.86
602.24
6.74%
651.69
654.20
-0.38%
674.46
688.01
-1.97%
EBITDA
151.67
114.07
32.96%
170.89
173.56
-1.54%
205.51
124.39
65.21%
204.86
194.01
5.59%
EBIDTM
19.20%
17.59%
21.00%
22.37%
23.97%
15.98%
23.30%
22.00%
Other Income
31.73
57.92
-45.22%
29.60
15.82
87.10%
14.02
16.50
-15.03%
9.04
15.88
-43.07%
Interest
0.79
1.08
-26.85%
0.63
1.51
-58.28%
0.94
2.98
-68.46%
0.88
0.92
-4.35%
Depreciation
17.71
21.77
-18.65%
17.85
22.59
-20.98%
17.71
18.33
-3.38%
21.96
22.70
-3.26%
PBT
164.90
149.14
10.57%
63.01
176.55
-64.31%
211.41
-634.32
-
126.93
587.41
-78.39%
Tax
43.82
38.31
14.38%
48.68
38.48
26.51%
54.90
26.84
104.55%
50.46
84.66
-40.40%
PAT
121.08
110.83
9.25%
14.33
138.07
-89.62%
156.51
-661.16
-
76.47
502.75
-84.79%
PATM
15.33%
17.09%
1.76%
17.80%
18.26%
-84.92%
8.70%
57.00%
EPS
7.15
6.54
9.33%
0.85
8.15
-89.57%
9.24
-39.03
-
4.51
29.68
-84.80%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Net Sales
3,340.26
3,198.86
3,224.38
3,128.12
2,871.45
2,908.47
2,837.91
3,362.91
2,607.70
2,692.06
2,455.38
Net Sales Growth
8.27%
-0.79%
3.08%
8.94%
-1.27%
2.49%
-15.61%
28.96%
-3.13%
9.64%
 
Cost Of Goods Sold
1,365.49
1,312.71
1,307.87
1,358.03
1,241.31
1,397.75
1,324.90
1,327.66
1,171.68
1,100.57
923.50
Gross Profit
1,974.77
1,886.15
1,916.51
1,770.09
1,630.14
1,510.72
1,513.02
2,035.25
1,436.02
1,591.49
1,531.87
GP Margin
59.12%
58.96%
59.44%
56.59%
56.77%
51.94%
53.31%
60.52%
55.07%
59.12%
62.39%
Total Expenditure
2,607.33
2,503.53
2,567.13
2,527.32
2,365.66
2,489.49
2,359.64
2,788.33
2,124.49
1,915.22
1,693.90
Power & Fuel Cost
-
26.08
33.36
27.94
26.44
27.82
25.97
31.17
23.85
22.50
26.70
% Of Sales
-
0.82%
1.03%
0.89%
0.92%
0.96%
0.92%
0.93%
0.91%
0.84%
1.09%
Employee Cost
-
614.69
628.55
537.20
523.40
483.01
443.37
493.02
362.05
295.52
278.36
% Of Sales
-
19.22%
19.49%
17.17%
18.23%
16.61%
15.62%
14.66%
13.88%
10.98%
11.34%
Manufacturing Exp.
-
106.55
107.89
115.55
110.55
108.26
118.09
367.24
127.78
113.62
111.44
% Of Sales
-
3.33%
3.35%
3.69%
3.85%
3.72%
4.16%
10.92%
4.90%
4.22%
4.54%
General & Admin Exp.
-
118.87
164.51
178.60
204.45
195.08
154.85
178.21
135.34
126.10
108.51
% Of Sales
-
3.72%
5.10%
5.71%
7.12%
6.71%
5.46%
5.30%
5.19%
4.68%
4.42%
Selling & Distn. Exp.
-
190.92
212.36
202.81
154.38
178.91
164.47
222.31
186.23
160.74
157.60
% Of Sales
-
5.97%
6.59%
6.48%
5.38%
6.15%
5.80%
6.61%
7.14%
5.97%
6.42%
Miscellaneous Exp.
-
133.71
112.58
107.20
105.12
98.67
127.99
168.72
117.55
96.17
157.60
% Of Sales
-
4.18%
3.49%
3.43%
3.66%
3.39%
4.51%
5.02%
4.51%
3.57%
3.58%
EBITDA
732.93
695.33
657.25
600.80
505.79
418.98
478.27
574.58
483.21
776.84
761.48
EBITDA Margin
21.94%
21.74%
20.38%
19.21%
17.61%
14.41%
16.85%
17.09%
18.53%
28.86%
31.01%
Other Income
84.39
110.58
79.01
102.32
54.54
73.07
123.18
258.80
222.30
223.90
186.59
Interest
3.24
3.53
6.34
0.55
0.19
0.25
0.42
0.47
0.33
0.33
0.33
Depreciation
75.23
79.28
82.68
48.59
37.99
26.35
24.95
25.35
19.88
17.84
20.41
PBT
566.25
723.10
647.25
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
Tax
197.86
192.35
212.55
237.28
189.24
174.37
202.25
279.27
229.78
272.48
176.20
Tax Rate
34.94%
34.94%
69.52%
34.76%
35.05%
34.11%
34.97%
36.96%
32.30%
32.66%
29.13%
PAT
368.39
358.15
93.20
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
PAT before Minority Interest
368.39
358.15
93.20
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.03%
11.20%
2.89%
14.24%
12.21%
11.58%
13.25%
14.17%
18.47%
20.87%
17.46%
PAT Growth
307.11%
284.28%
-79.07%
26.99%
4.13%
-10.46%
-21.05%
-1.09%
-14.28%
31.10%
 
EPS
21.75
21.14
5.50
26.29
20.70
19.88
22.20
28.12
28.43
33.17
25.30

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Shareholder's Funds
1,499.08
1,820.60
2,139.83
2,057.33
2,006.86
2,183.25
1,828.98
1,989.73
2,006.83
1,935.70
Share Capital
169.41
169.41
169.41
84.70
84.70
84.70
84.70
84.70
84.70
84.70
Total Reserves
1,329.67
1,651.20
1,970.42
1,972.63
1,922.15
2,098.55
1,744.28
1,905.03
1,922.13
1,851.00
Non-Current Liabilities
178.68
180.19
2,860.37
2,632.47
3,699.70
3,498.32
197.04
158.59
158.45
172.78
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.02
0.18
0.58
0.99
1.60
2.63
3.61
4.14
4.59
Long Term Provisions
259.50
261.74
2,920.20
2,733.36
3,786.83
3,592.19
272.21
242.29
236.05
224.81
Current Liabilities
1,332.47
1,021.95
2,804.07
2,948.98
881.09
783.63
1,106.55
888.91
836.40
859.59
Trade Payables
464.47
357.06
405.81
505.86
278.93
327.74
308.04
285.63
237.37
200.58
Other Current Liabilities
450.11
222.85
802.71
842.35
390.47
202.82
130.09
84.13
86.82
67.25
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
417.90
442.04
1,595.54
1,600.77
211.69
253.08
668.42
519.15
512.21
591.77
Total Liabilities
3,010.23
3,022.74
7,804.27
7,638.78
6,587.65
6,465.20
3,132.57
3,037.23
3,001.68
2,968.07
Net Block
384.27
756.59
429.99
322.81
252.71
204.04
123.08
100.09
89.42
99.15
Gross Block
614.71
1,452.35
559.05
405.89
299.09
228.36
363.34
343.22
316.18
315.80
Accumulated Depreciation
230.44
695.76
129.06
83.08
46.38
24.32
240.26
243.13
226.76
216.65
Non Current Assets
807.58
1,247.87
4,445.06
4,103.26
4,752.54
4,087.05
545.58
413.30
355.01
363.01
Capital Work in Progress
13.21
120.12
1,002.64
922.90
605.46
267.67
115.22
61.86
43.79
16.19
Non Current Investment
1.35
1.49
1.69
1.84
5.40
6.04
0.06
0.06
10.06
54.98
Long Term Loans & Adv.
401.71
362.49
3,002.88
2,850.97
3,882.49
3,609.24
296.09
237.73
194.55
157.01
Other Non Current Assets
7.03
7.17
7.84
4.75
6.47
0.06
11.13
13.55
17.19
35.68
Current Assets
2,202.65
1,774.88
3,359.21
3,535.52
1,835.10
2,378.15
2,586.98
2,623.94
2,646.67
2,605.06
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
10.00
44.91
57.21
Inventories
546.70
483.03
486.49
500.18
425.80
525.87
375.58
346.97
285.15
333.44
Sundry Debtors
215.60
99.80
120.49
146.96
170.80
126.56
100.32
96.39
115.90
85.31
Cash & Bank
1,157.98
1,083.20
1,171.35
1,296.41
899.61
1,391.90
1,910.61
2,041.58
2,066.77
2,014.36
Other Current Assets
282.38
48.58
112.30
78.72
338.90
333.82
200.47
128.99
133.94
114.74
Short Term Loans & Adv.
57.64
60.27
1,468.58
1,513.25
232.20
310.58
112.04
71.19
58.18
50.12
Net Current Assets
870.18
752.93
555.14
586.54
954.01
1,594.52
1,480.43
1,735.03
1,810.27
1,745.46
Total Assets
3,010.23
3,022.75
7,804.27
7,638.78
6,587.64
6,465.20
3,132.56
3,037.24
3,001.68
2,968.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Cash From Operating Activity
577.93
490.50
409.49
472.80
234.37
138.90
337.64
281.31
313.59
335.37
PBT
723.10
647.25
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
Adjustment
-25.64
13.17
-31.36
-12.17
-46.47
-96.01
-173.66
-156.37
-159.63
-139.38
Changes in Working Capital
45.76
44.07
-4.19
164.56
-26.69
-124.41
-36.90
11.45
56.35
-73.09
Cash after chg. in Working capital
743.21
704.49
618.41
674.55
392.29
355.67
597.00
540.37
879.30
714.86
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-146.95
-179.72
-194.24
-202.01
-160.59
-205.95
-252.43
-244.09
-318.38
-316.53
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-18.34
-34.26
-14.69
0.25
2.67
-10.82
-6.93
0.00
0.00
0.00
Cash From Investing Activity
418.59
-56.84
-153.45
-104.19
300.64
499.02
180.01
188.98
-109.65
358.03
Net Fixed Assets
944.55
-10.78
-232.90
-424.24
-408.52
-61.62
-73.47
-45.11
-27.98
39.27
Net Investments
0.15
0.20
23.26
3.56
0.64
-5.96
10.00
44.92
57.21
0.55
Others
-526.11
-46.26
56.19
316.49
708.52
566.60
243.48
189.17
-138.88
318.21
Cash from Financing Activity
-696.14
-427.62
-358.36
-306.63
-510.76
-638.33
-496.99
-494.14
-440.63
-394.81
Net Cash Inflow / Outflow
300.38
6.03
-102.33
61.97
24.24
-0.42
20.66
-23.85
-236.69
298.59
Opening Cash & Equivalents
104.81
98.78
201.10
139.13
114.89
115.30
94.93
137.67
374.36
75.77
Closing Cash & Equivalent
405.19
104.81
98.78
201.10
139.13
114.89
115.59
113.82
137.67
374.36

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Book Value (Rs.)
88.49
107.47
126.31
121.44
118.46
128.88
107.96
117.45
118.46
114.26
ROA
11.87%
1.72%
5.77%
4.93%
5.16%
7.84%
15.44%
15.95%
18.82%
10.65%
ROE
21.58%
4.71%
21.22%
17.26%
16.08%
18.75%
24.95%
24.10%
28.50%
22.05%
ROCE
33.38%
15.76%
32.54%
26.56%
24.39%
28.82%
39.53%
35.54%
42.24%
31.05%
Fixed Asset Turnover
3.10
3.21
6.48
8.21
11.38
9.59
9.82
8.13
8.74
7.40
Receivable days
17.99
12.47
15.60
20.03
18.09
14.59
10.35
14.45
13.29
9.62
Inventory Days
58.75
54.88
57.56
58.36
57.89
57.97
38.01
43.02
40.86
45.01
Payable days
62.30
57.89
73.24
66.07
51.56
53.81
43.72
49.18
47.40
62.14
Cash Conversion Cycle
14.44
9.45
-0.07
12.32
24.42
18.75
4.64
8.28
6.75
-7.51
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
156.89
49.26
1232.59
2856.45
2045.74
1373.88
1612.26
2146.51
2497.59
1848.25

News Update:


  • GlaxoSmithKline Pharmaceuticals to transfer rights of Iodex and Ostocalcium brands to GSK Asia
    27th Jul 2021, 09:16 AM

    The transaction is expected to be completed before the end of the year

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.